Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA gives the green light to the first Humira biosimilar

September 26, 2016 Sales and Marketing AbbVie, Amgen, Amjevita, FDA, Humira

Amgen’s Amjevita has been given the go ahead for all eligible indications of its reference product, including moderate-to-severe rheumatoid arthritis, …
News

NICE approval for restricted-use hypophosphatasia therapy

September 23, 2016 Medical Communications, Sales and Marketing Alexion Pharmaceuticals, Strensiq, hypophosphatasia

The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the use of Alexion Pharmaceutical’s Strensiq …
News

Top ten stories in the pharmaceutical industry this week

September 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday (and print day for the Pharmafocus October edition!) and its been a pretty explosive week, from new and …
News

Novo Nordisk to provide discounted insulin to poorest nations

September 23, 2016 Medical Communications, Sales and Marketing Novo Nordisk, diabetes, insulin

Danish pharma firm Novo Nordisk has announced its intention to provide insulin at discounted prices to the world’s poorest nations …
News

DNA damage response biotech launches with £25m funding

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dna damage response, funding

Cambridge-based Artios Pharma has officially launched after raising £25 million in series A financing from US and European life science …
News

193 countries sign UN declaration to fight drug-resistant infection

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeremy Hunt, UN, drug-resistant infection

A historic UN declaration to fight drug-resistant infection across the globe has been signed by 193 countries at the United …
News

Gilead terminates Phase II/III study for ulcerative colitis antibody

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, ulcerative colitis

Gilead has put the brakes on a Phase II/III study of its anti-MMP9 antibody GS-5745 for the treatment of ulcerative …
News

AZ withdraws European filing for ovarian cancer therapy

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, cediranib, ovarian cancer

AstraZeneca is no longer seeker European approval for its oral multi-VEGF receptor inhibitor cediranib for treatment of ovarian cancer after withdrawing …
News

EpiPen CEO appears before US lawmakers to defend “sickening” price hikes

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen

Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …
News

GSK appoints Emma Walmsley as first female CEO

September 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment

GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
Appointment

GE Healthcare doubles India investment

September 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing GE Healthcare, India

UK firm GE Healthcare is set to double its investment in India as it aims for revenues of £750 million …
News

Teva and Regeneron team up for $2.6 billion pain treatment development

September 21, 2016 Research and Development, Sales and Marketing Regeneron, Teva, fasinumab, osteoarthritis

Teva and Regeneron have entered an agreement worth up to $2.6 billion to develop and market the latter’s experimental nerve …
News

Allergan expands NASH portfolio with $1.7 billion in acquisitions

September 21, 2016 Research and Development, Sales and Marketing Akarna Therapeutics, Allergan, Tobira Therapeutics, acqusition, nash

Allergan has gone on a spending spree this week, snapping up clinical-stage biotech Tobira Therapeutics and privately-held Akarna Therapeutics for …
News

Bayer CEO defends $66 billion Monsanto acquisition

September 20, 2016 Manufacturing and Production, Sales and Marketing Bayer, Werner Baumann, monsanto

Bayer AG’s chief executive Werner Baumann has spoken in defence of the company’s move last week to acquire US agricultural …
News

GSK appoints Emma Walmsley as CEO

September 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, appointment

GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
News
The Gateway to Local Adoption Series

Latest content

Major funding opportunity opens for early cancer diagnostics

September 4, 2026

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026

CEPI backs African-led Bundibugyo Ebola vaccine development

September 3, 2026

Cytomos appoints life sciences executive to board

September 2, 2026

Cell therapy partnership aims to bring liver disease treatment closer to US patients

September 1, 2026